media

Encycle Therapeutics Launches Ground-Breaking Chemistry Platform

Platform for cyclizing peptides promises to increase efficiency of early-stage drug discovery

BOSTON, June 18, 2012 – Encycle Therapeutics, a MaRS Innovation spin-off company, has created a ground-breaking chemistry platform for cyclizing peptides that promises to increase the efficiency of the early-stage drug discovery process.

Peptides have long been sought after as therapeutics due to their high specificity — they can hit specific cellular targets, especially complex protein-protein interaction targets implicated in cancer, cardiovascular disease and metabolic disorders.

National Post, Financial Post spotlight Flybits’ expansion to Tech City, London (U. K.)

June 18, 2012
Susanne Staer
Flybits

The Financial Post and the National Post each ran a feature article June 18, 2012 concerning the United Kingdom’s efforts to attract Canadian-based technology start-ups seeking entrance into European markets.

Flybits, a Mars Innovation spin-off company based on the research of Ryerson University professor Hossein Rahnama, was among those profiled.

The Accelerator Gazette Interviews Dr. Hossein Rahnama About Student Entrepreneurship

June 14, 2012
Susanne Staer
Flybits

Ryerson University, one of MaRS Innovation’s 16 member institutions, has created the Digital Media Zone (DMZ) to give student entrepreneurs and researchers — or anyone connected with a great idea connected to their campus — the space they need to grow their ideas.

Dr. Hossein Rahnama, the DMZ’s research director and a Ryerson University professor, was interviewed this week by The Accelerator Gazette about Ryerson’s approach to accelerating and incubating technologies.

OtoSim Inc. Makes a Sound Pitch on BNN

OtoSim listens to the Verdict on BNN's The Pitch — Louis Hui (far left) listens to the panel’s comments on BNN’s The Pitch.

OtoSim Inc., a MaRS Innovation spin-off company, made its debut on Business News Network’s The Pitchon June 1, 2012.

Louis Hui, OtoSim’s business development manager, had 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts.

OtoSim Inc. to Appear on BNN’s The Pitch

OtoSim Inc., a MaRS Innovation spin-off company, is taping an appearance on Business News Network’s The Pitch on May 22, 2012.

Louis Hui, OtoSim’s business development manager, will have 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts.

ScarX Therapeutics Featured on Front Page of the Globe and Mail

MaRS Innovation’s ScarX Therapeutics, a strategic partnership with The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek), was featured on the front page of the Globe and Mail on May 7, 2010.

Read the article on Globe and Mail.com (note that depending on when you’re accessing this page, the Globe‘s content may be subject to a pay wall).

MaRS Innovation Forms Strategic Drug-Development Partnership with NovoTek Therapeutics Inc. in China

MaRS Innovation (MI), The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek) have announced a strategic partnership to co‐develop, and bring to the Chinese market, a novel therapeutic cream aimed at reducing scar formation post surgery.

This project was covered in The Globe and Mail on May 7, 2012.

Encycle Therapeutics Launches Ground-Breaking Chemistry Platform

National Post, Financial Post spotlight Flybits’ expansion to Tech City, London (U. K.)

The Accelerator Gazette Interviews Dr. Hossein Rahnama About Student Entrepreneurship

OtoSim Inc. Makes a Sound Pitch on BNN

OtoSim Inc. to Appear on BNN’s The Pitch

ScarX Therapeutics Featured on Front Page of the Globe and Mail

MaRS Innovation Forms Strategic Drug-Development Partnership with NovoTek Therapeutics Inc. in China

Quick Links

Contact Us